Lisa Gill
Stock Analyst at JP Morgan
(3.22)
# 1,086
Out of 5,122 analysts
133
Total ratings
50%
Success rate
1.56%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $343.63 | +15.53% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $274.87 | +41.52% | 11 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $44.22 | +13.07% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $76.16 | +32.62% | 6 | Dec 17, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $23 | $21.37 | +7.65% | 6 | Dec 17, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $32 → $33 | $22.02 | +49.86% | 6 | Nov 13, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $6 → $5 | $2.20 | +127.27% | 2 | Nov 11, 2025 | |
| PGNY Progyny | Maintains: Neutral | $25 → $26 | $22.88 | +13.64% | 1 | Nov 11, 2025 | |
| COR Cencora | Maintains: Overweight | $344 → $417 | $332.77 | +25.31% | 3 | Nov 11, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $291 → $317 | $276.71 | +14.56% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $275.84 | +35.95% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $821 → $853 | $827.95 | +3.03% | 14 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $7.90 | +26.58% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $188.72 | +0.68% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $23.25 | +29.03% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $34.21 | +19.85% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $193.16 | +32.53% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $209.34 | -30.73% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $35.35 | -49.08% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $7.82 | -36.06% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $14.26 | +96.35% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $4.91 | +83.30% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $8.73 | +106.19% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $179.54 | +120.01% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $208.42 | -10.76% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $192.08 | -27.11% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $498.62 | -33.42% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.69 | +1,201.33% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.03 | +13.88% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $74.76 | +11.02% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $41.49 | +136.20% | 1 | Jan 6, 2023 |
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $343.63
Upside: +15.53%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $274.87
Upside: +41.52%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $44.22
Upside: +13.07%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $76.16
Upside: +32.62%
Alignment Healthcare
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $21.37
Upside: +7.65%
Privia Health Group
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $22.02
Upside: +49.86%
GoodRx Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.20
Upside: +127.27%
Progyny
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $22.88
Upside: +13.64%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $344 → $417
Current: $332.77
Upside: +25.31%
Labcorp Holdings
Nov 7, 2025
Maintains: Overweight
Price Target: $291 → $317
Current: $276.71
Upside: +14.56%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $275.84
Upside: +35.95%
Sep 26, 2025
Maintains: Overweight
Price Target: $821 → $853
Current: $827.95
Upside: +3.03%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $7.90
Upside: +26.58%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $188.72
Upside: +0.68%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $23.25
Upside: +29.03%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $34.21
Upside: +19.85%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $193.16
Upside: +32.53%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $209.34
Upside: -30.73%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $35.35
Upside: -49.08%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $7.82
Upside: -36.06%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $14.26
Upside: +96.35%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $4.91
Upside: +83.30%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $8.73
Upside: +106.19%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $179.54
Upside: +120.01%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $208.42
Upside: -10.76%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $192.08
Upside: -27.11%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $498.62
Upside: -33.42%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.69
Upside: +1,201.33%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.03
Upside: +13.88%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $74.76
Upside: +11.02%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $41.49
Upside: +136.20%